Why this Dallas biotech firm is cutting roughly 35% of its headcount
March 31, 2022 at 18:29 PM EDT
The firm hopes the move will extend Its cash runway to the fourth quarter of 2023.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|